Align Technology Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 3.69, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the first quarter 2026. Average collection period, for Align Technology Inc 's accounts receivable remained unchanged at 99 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 208 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 1075 to 1629.

What is Receivable Turnover Ratio?
What is Align Technology Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALGN Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	5.95 %	10.65 %	8.78 %	9.42 %	11.7 %
Y / Y Revenue Change	6.18 %	5.19 %	1.78 %	-1.51 %	-1.78 %
Receivable Turnover Ratio (TTM)	3.69	3.68	3.73	3.79	3.89
ALGN's Total Ranking	# 1629	# 1075	# 1557	# 979	# 2652
Accounts Receivable average collection period days	99	99	98	96	94
Seq. Receivable Change	2.12 %	0.22 %	-1.51 %	5.11 %	6.66 %
Seq. Revenue Change	-0.76 %	5.26 %	-1.67 %	3.37 %	-1.69 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 91
Healthcare Sector	# 209
Overall Market	# 1629

Receivable Turnover Ratio Statistics
High	Average	Low
1.02	0.78	0.57
(Dec 31 2018)		(Dec 31 2020)

ALGN Company Profile • Back to ALGN Efficiency Comparisons • Compare ALGN Receivables Turnover Ratio to its Competitors

Financial Statements
Align Technology Inc 's Accounts Receivable	$ 1,125 Millions	Visit ALGN's Balance sheet
Align Technology Inc 's Sales TTM	$ 4,094 Millions	Visit ALGN's Income Statement
Sources of ALGN's Revenues		Visit ALGN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALGN's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALGN's Growth Rates	ALGN's Roa	ALGN's Inventory Turnover Ratio	ALGN's Dividend Comparisons
ALGN's Profitability Ratios	ALGN's Roi	ALGN's Asset Turnover Ratio	ALGN's Dividend Growth
ALGN's Valuation Ratios	ALGN's Roe	ALGN's Financial Strength Ratios	ALGN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Irhythm Holdings Inc	10.00	$ 787.387 Millions	$ 78.720 Millions
C4 Therapeutics Inc	9.97	$ 34.861 Millions	$ 3.496 Millions
Biodesix Inc	9.94	$ 96.096 Millions	$ 9.665 Millions
Radnet Inc	9.87	$ 2,144.442 Millions	$ 217.223 Millions
Lensar Inc	9.87	$ 57.704 Millions	$ 5.847 Millions
X4 Pharmaceuticals Inc	9.69	$ 9.014 Millions	$ 0.931 Millions
Septerna Inc	9.64	$ 72.255 Millions	$ 7.499 Millions
Encompass Health Corporation	9.63	$ 6,066.400 Millions	$ 629.625 Millions
Biolife Solutions Inc	9.51	$ 99.673 Millions	$ 10.478 Millions
Biofrontera Inc	9.49	$ 42.983 Millions	$ 4.530 Millions
United Therapeutics Corporation	9.47	$ 3,169.800 Millions	$ 334.800 Millions
Tandem Diabetes Care Inc	9.34	$ 1,023.420 Millions	$ 109.550 Millions
Sunshine Biopharma Inc	9.33	$ 35.493 Millions	$ 3.804 Millions
The Oncology Institute Inc	9.30	$ 545.764 Millions	$ 58.671 Millions
The Pennant Group Inc	9.28	$ 1,023.227 Millions	$ 110.305 Millions
Enanta Pharmaceuticals Inc	9.26	$ 69.213 Millions	$ 7.477 Millions
Volitionrx Limited	9.23	$ 2.466 Millions	$ 0.267 Millions
Lucid Diagnostics Inc	9.11	$ 5.134 Millions	$ 0.564 Millions
Soleno Therapeutics Inc	9.09	$ 285.008 Millions	$ 31.369 Millions
Dariohealth Corp	9.03	$ 20.983 Millions	$ 2.324 Millions
Harmony Biosciences Holdings inc	9.02	$ 899.247 Millions	$ 99.660 Millions
Tactile Systems Technology Inc	9.01	$ 343.414 Millions	$ 38.110 Millions
Ardent Health Inc	8.99	$ 6,428.975 Millions	$ 715.036 Millions
Sanuwave Health Inc	8.91	$ 44.328 Millions	$ 4.973 Millions
Biocryst Pharmaceuticals Inc	8.89	$ 885.716 Millions	$ 99.648 Millions
Madrigal Pharmaceuticals Inc	8.81	$ 1,132.490 Millions	$ 128.587 Millions
Inogen Inc	8.80	$ 351.497 Millions	$ 39.926 Millions
Grail Inc	8.77	$ 156.120 Millions	$ 17.809 Millions
Eyepoint Inc	8.76	$ 7.614 Millions	$ 0.869 Millions
Zomedica Corp	8.73	$ 33.355 Millions	$ 3.820 Millions

Date modified: 2026-09-08T15:11:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.